{"id":"W2073529780","doi":"10.1007/s40261-013-0088-7","title":"Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Inhaled Doses of Umeclidinium in Healthy Subjects: Two Randomized Studies","year":2013,"lang":"en","type":"article","venue":"Clinical Drug Investigation","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"GlaxoSmithKline","keywords":"Medicine; Tolerability; Pharmacodynamics; Pharmacokinetics; Crossover study; Dosing; Adverse effect; Ipratropium bromide; Placebo; Anesthesia; COPD; Tiotropium bromide; Pharmacology; Bronchodilator; Internal medicine; Asthma; Lung","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005755933,0.00224061,0.004700767,0.0006495537,0.0008253554,0.001197754,0.001620486,0.003116571,0.004072551],"category_scores_gemma":[0.006615577,0.001365975,0.003600825,0.000750186,0.002923489,0.001651658,0.0007521642,0.002647088,0.0007201325],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001236603,"about_ca_system_score_gemma":0.001182443,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001291779,"about_ca_topic_score_gemma":0.001525589,"domain_scores_codex":[0.9949603,0.003158964,0.0004434378,0.0006792491,0.0003423269,0.000415674],"domain_scores_gemma":[0.9932372,0.002786347,0.001820546,0.0009275233,0.0004073017,0.0008210884],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9840316,0.004923617,0.001268323,0.0001979293,0.0009871662,0.00002882782,0.00005331648,0.0001454163,0.002317823,0.000025045,0.00008637603,0.005934526],"study_design_scores_gemma":[0.7894723,0.1987536,0.007545268,0.0000212535,0.001886818,0.00006918719,0.00004690824,0.0003272639,0.001368051,0.00009999747,0.0003621849,0.00004707778],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9940161,0.002137081,0.0008427459,0.0001413053,0.00008920495,0.001785857,0.000464122,0.00005980655,0.0004637777],"genre_scores_gemma":[0.9923592,0.001394913,0.001736752,0.0003867015,0.0002988175,0.001923713,0.0007425337,0.0000304309,0.001126957],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005755933,"threshold_uncertainty_score":0.03044063,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0649579216921815,"score_gpt":0.4054841485212134,"score_spread":0.3405262268290319,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}